Sign in

LabMed Discovery

@labmed2025.bsky.social
4 followers 7 following 112 posts

LMD aims at fostering collaboration and knowledge exchange between medical technology and clinical medicine by serving a diverse audience of researchers, clinical physicians, and scholars in precision medicine, and laboratory medicine.

PostsRepliesMedia
LabMed Discovery @labmed2025.bsky.social · 30/09/2026
🤖 AI is transforming the entire laboratory testing process—but high performance ≠ clinical value. #LabMedDiscovery Perspective explores AI from pre-analytics to interpretation, addressing validation, bias, explainability, cybersecurity, ethics & governance. www.sciencedirect.com/science/arti...
000
LabMed Discovery @labmed2025.bsky.social · 30/09/2026
🔬 Beyond a single tumor snapshot! New in LabMed Discovery: a review proposes precision care for gastric & colorectal cancers through: 📷 Serial ctDNA monitoring AI integration 📷 #PrecisionOncology #LiquidBiopsy www.sciencedirect.com/science/arti...
000
LabMed Discovery @labmed2025.bsky.social · 30/09/2026
🧬 RNA m5C in cancer: ready for the clinic? 📷 Key insights: assay limitations, reliable quantification & a roadmap to clinical valid🎯 #RNA #CancerBiomarkers www.sciencedirect.com/science/arti...
000
LabMed Discovery @labmed2025.bsky.social · 30/09/2026
www.sciencedirect.com/science/arti...
000
LabMed Discovery @labmed2025.bsky.social · 30/09/2026
🧬 Antibodies meet programmable nucleic acids. A new #LabMedDiscovery review explores antibody–oligonucleotide conjugates (AOCs)— 🔬 One platform, bridging diagnostics and therapeutics www.sciencedirect.com/science/arti... #AOC #LaboratoryMedicine #MultiOmics #RNA #Diagnostics
000
LabMed Discovery @labmed2025.bsky.social · 30/09/2026
🇨🇳 Happy National Day! On this special occasion, #LabMedDiscovery extends our warmest wishes to our authors, reviewers, Editorial Board members, readers, and partners in China and around the world. United by science, connected through discovery. 🌏 Together, we advance labmed
010
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
Ceftobiprole against resistant infections: where does it fit? This LMD review explores anti-MRSA activity, PK/PD, clinical evidence & safety—and why antimicrobial stewardship matters. doi.org/10.1016/j.lm... #LabMedDiscovery #AMR #Ceftobiprole
110
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
What fuels kidney fibrosis in IgG4-related disease? This LMD review explores how metabolic reprogramming and immune dysregulation intertwine—and highlights potential targets for future therapies. doi.org/10.1016/j.lm... #LabMedDiscovery #IgG4 #Fibrosis
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
Could blood offer clues to depression? This LMD review explores blood metabolites, AI and their potential to complement clinical assessment. Promising biomarkers—but broader validation is needed. doi.org/10.1016/j.lm... #LabMedDiscovery #Metabolomics #Depression
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
Mitophagy in blood cancers: an ally—or a vulnerability? This LMD review explores its dual roles in tumor survival and cell death, plus its impact on immunity. Could context-specific modulation offer new therapeutic avenues? doi.org/10.1016/j.lm... #LabMedDiscovery #Mitophagy
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
🌕 Happy Mid-Autumn Festival from the LabMed Discovery editorial team! To our editors, reviewers, authors and colleagues worldwide: thank you for your support. Wishing you and your loved ones joy, peace and cherished moments together. #MidAutumnFestival #LMD
010
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
Tired of non-specific SMA results? Anti-F-actin immunoblotting adds disease specificity to AIH-1 diagnosis — 87.5% specificity, 81.4% accuracy, a 9-in-1 antibody panel. The lab toolbox just got smarter. 🔬 #AutoimmuneHepatitis #ClinicalChemistry# sciencedirect.com/science/arti...
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
📸 New faces, shared ambition! 🌏 LabMed Discovery’s 2nd Editorial Board Meeting | Shanghai, Sept 15 🤝 Welcoming new board members and shaping LMD’s next chapter together. 🔬 Connecting minds. Advancing laboratory medicine. #LMD #LaboratoryMedicine
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
🎤 LMD takes the stage in Shanghai! 📚 LabMed Discovery was invited to deliver a talk at a conference on science, technology and journals. 🤝 Sharing perspectives and building connections to advance scholarly publishing. #LMD #ScholarlyPublishing
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
📚 Learning together, growing together! LMD was delighted to join a training event organized by Wiley. 🤝 Thank you for the opportunity to learn, exchange ideas and connect with publishing colleagues! #LMD #Wiley #ScholarlyPublishing
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
🔬 LMD at NCLM 2026! 📍 Wuhan, Sept 17–19 LabMed Discovery was honored to join the 20th National Congress of Laboratory Medicine. 🤝 Connecting with colleagues and bringing laboratory medicine research to a global audience! #LMD #NCLM2026 #LaboratoryMedicine
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
✍️ From discovery to publication! Ruijin Hospital’s editorial office welcomed two Nature editors for a masterclass in scientific writing and publishing. 🤝 Bringing researchers and editors together to exchange insights! #LMD #NatureMasterclasses #SciComm
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
🔬 Connecting diagnostics with clinical practice! LMD’s editorial team was honored to deliver remarks at CSCO’s clinical case reasoning competition. 🌏 Sharing diagnostic insights with a global audience through LabMed Discovery. #LMD #CSCO #LaboratoryMedicine
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
📚 Eight journals, one shared mission: advancing medicine! Ruijin Hospital’s journal portfolio, including LabMed Discovery, was showcased at the Shanghai journal conference. 🌏 Connecting research, clinical practice and global readers. #LMD #RuijinHospital #SciComm
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
🤖 What makes AI safe for the clinical lab? New in LabMed Discovery: Lippi and colleagues explore: 🔬 Validation & continuous monitoring ⚖️ Ethics & governance 👩‍⚕️ Human oversight 🔗 doi.org/10.1016/j.lm... #AI #LaboratoryMedicine #PatientSafety
010
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
🔬 Beyond a single tumor snapshot! New in LabMed Discovery: a review proposes precision care for gastric & colorectal cancers through: 🧬 Multi-omics 🩸 Serial ctDNA monitoring 🤖 AI integration 🔗 doi.org/10.1016/j.lm... #PrecisionOncology #LiquidBiopsy
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
🧬 RNA m5C in cancer: ready for the clinic? 🔬 A new review in LabMed Discovery examines the measurement gap. 🎯 Key insights: assay limitations, reliable quantification & a roadmap to clinical validation. 🔗 doi.org/10.1016/j.lm... #RNA #CancerBiomarkers
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
LabMed Discovery 🧬 Can human genetics unlock new clues to thyroid disease? 🌿 PITO links genetic evidence, molecular networks & traditional Chinese medicine to prioritize potential targets for hyper- and hypothyroidism. 🔎 Explore the latest in LMD! #Thyroid sciencedirect.com/science/arti...
000
LabMed Discovery @labmed2025.bsky.social · 26/09/2026
Hours, not weeks. Scientists built a "lab on a chip" that names the exact lung bacteria making you sick — from a single sample, up to 5 species at once, including the drug-resistant look-alikes. CRISPR + nanodroplets just changed TB testing. sciencedirect.com/science/arti...
143
LabMed Discovery @labmed2025.bsky.social · 01/09/2026
Precision oncology isn’t about more data—it’s about the right decision for every patient. 🎯 In #LabMedDiscovery, Khosrow Adeli explores how genomics, liquid biopsy and AI can advance equitable, patient-centred cancer care. 📷https://doi.org/10.1016/j.lmd. 2026.100142 #PrecisionOncology
000
LabMed Discovery @labmed2025.bsky.social · 01/09/2026
One molecule. Two game-changing missions. 🧬A new #LabMedDiscovery review reveals how antibody–oligonucleotide conjugates are reshaping protein profiling and targeted RNA therapeutics. Read now 🔗 doi.org/10.1016/j.lmd. 2026.100143 #AOC #Proteomics
010
LabMed Discovery @labmed2025.bsky.social · 30/08/2026
One molecule. Two game-changing missions. 🧬 Can AOCs both decode proteins and deliver RNA with precision? A new #LabMedDiscovery review reveals how antibody–oligonucleotide conjugates are reshaping protein profiling and targeted RNA therapeutics. Read now 🔗 doi.org/10.1016/j.lm... #AOC #Proteomics
000
LabMed Discovery @labmed2025.bsky.social · 30/08/2026
Precision oncology isn’t about more data—it’s about the right decision for every patient. 🎯 In #LabMedDiscovery, Khosrow Adeli explores how genomics, liquid biopsy and AI can advance equitable, patient-centred cancer care. 🔗 doi.org/10.1016/j.lm... #PrecisionOncology
000
LabMed Discovery @labmed2025.bsky.social · 15/08/2026
🌍 Call for Papers | LabMed Discovery How can laboratory innovation transform clinical decision-making and advance precision medicine? 🔗 Submit your manuscript: www.editorialmanager.com/lmd/Default....
🌍 Call for Papers | LabMed Discovery

How can laboratory innovation transform clinical decision-making and advance precision medicine?

LabMed Discovery (LMD) warmly invites researchers, clinicians and laboratory medicine professionals worldwide to submit high-quality original research, reviews, perspectives and editorials.

We particularly welcome contributions in:

• Clinical diagnostics and laboratory innovation
• Biomarker discovery, validation and clinical application
• Precision medicine and molecular diagnostics
• Translational laboratory science
• Omics, artificial intelligence and emerging technologies
• Point-of-care testing and next-generation diagnostic platforms

Dedicated to connecting laboratory science with clinical practice, LMD provides an international platform for innovative research with meaningful diagnostic and translational value.

Share your discoveries. Expand their international visibility. Help shape the future of laboratory medicine.

🔗 Submit your manuscript:
https://www.editorialmanager.com/lmd/Default.aspx

📖 Explore LabMed Discovery:
https://www.sciencedirect.com/journal/labmed-discovery/

📧 Editorial Office: labmed@rjh.com.cn

We look forward to receiving your work and welcoming you to the global LMD scholarly community.

#LabMedDiscovery #CallForPapers #LaboratoryMedicine #ClinicalDiagnostics #PrecisionMedicine #Biomarkers #MolecularDiagnostics #TranslationalMedicine #ClinicalResearch
000
LabMed Discovery @labmed2025.bsky.social · 15/08/2026
How close are we to a Nipah virus vaccine? In LabMed Discovery, Rengarajan maps 5 leading platforms—subunit, viral vector, VLP, mRNA and DNA—and the safety, clinical-trial and scalability gaps still ahead. Read: doi.org/10.1016/j.lm... #NipahVirus #Vaccines
110
LabMed Discovery @labmed2025.bsky.social · 15/08/2026
Beyond the bacterium lies a nanoscale signaling system. Wang et al. review how Akkermansia muciniphila extracellular vesicles connect gut-barrier integrity, metabolism, immunity, cancer and the gut–brain axis—with promise for cell-free theranostics. doi.org/10.1016/j.lm...
120
LabMed Discovery @labmed2025.bsky.social · 15/08/2026
Where a biomarker is located may matter as much as what it is. This review examines how spatial and single-cell omics decode tumor–immune ecosystems and advance biomarker discovery for immunotherapy response, resistance, and toxicity. doi.org/10.1016/j.lm... #SpatialOmics #Immunotherapy
010
LabMed Discovery @labmed2025.bsky.social · 15/08/2026
Can a next-generation skin test strengthen TB detection in children? A Phase III trial in LabMed Discovery found that C-TST achieved 83.0% sensitivity, 100% specificity and no serious adverse events. Read open access: doi.org/10.1016/j.lm... #Tuberculosis #Pediatrics #LabMedicine
000
LabMed Discovery @labmed2025.bsky.social · 15/08/2026
Summarizes the systemic endocrine functions of undercarboxylated osteocalcin (Glu-OCN), a bone-derived hormone. We elucidate its protective mechanisms in non-alcoholic fatty liver disease, diabetes, osteoporosis, atherosclerosis, Alzheimer’s disease and depression DOI: 10.1016/j.lmd.2025.100074
000
LabMed Discovery @labmed2025.bsky.social · 15/08/2026
Where a biomarker is located may matter as much as what it is. This review examines how spatial and single-cell omics decode tumor–immune ecosystems and advance biomarker discovery for immunotherapy response, resistance, and toxicity. doi.org/10.1016/j.lm... #SpatialOmics #Immunotherapy
000
LabMed Discovery @labmed2025.bsky.social · 15/08/2026
Same dose. Same duration. Different outcomes. In 80 children with ASD, a vitamin D3 nanoemulsion produced greater bioavailability and improvements in selected behavioral and language measures compared with marketed vitamin D3. doi.org/10.1016/j.lm... #AutismResearch #Nanomedicine
000
LabMed Discovery @labmed2025.bsky.social · 15/08/2026
Where a biomarker is located may matter as much as what it is. This review examines how spatial and single-cell omics decode tumor–immune ecosystems and advance biomarker discovery for immunotherapy response, resistance, and toxicity. doi.org/10.1016/j.lm... #SpatialOmics #Immunotherapy
000
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
www.sciencedirect.com/journal/labm...
000
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
🚀 Publish your research with LabMed Discovery! 🌍 Open Access — Your research is freely accessible worldwide 💰 No APC for authors — covered by Ruijin Hospital, Shanghai Jiao Tong University School of Medicine ⚡ Fast & rigorous peer review — Ensuring quality and efficiency
000
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
🎉 LabMed Discovery Vol. 3 Issue 2 is now live! #AI in computational pathology, sleep disorders & blood-brain barrier #massspectrometry, ferroptosis in T cells, and single-cell.... sciencedirect.com/journal/labm...
000
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
🚀 Publish your research with LabMed Discovery! www.sciencedirect.com/journal/labm... 🌍 Open Access — Your research is freely accessible worldwide 💰 No APC for authors ⚡ Fast & rigorous peer review — Ensuring quality and efficiency 📢 Global visibility — Amplify the impact of your discoveries
000
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
🚀 Publish your research with LabMed Discovery! 🌍 Open Access — Your research is freely accessible worldwide 💰 No APC for authors ⚡ Fast & rigorous peer review — Ensuring quality and efficiency 📢 Global visibility — Amplify the impact of your discoveries
000
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
LMD welcomes high-quality research across interdisciplinary fields, including laboratory diagnostics, precision medicine, biomarkers, artificial intelligence, multi-omics, translational medicine, and emerging technologies. support from Ruijin Hospital and Elsevier 📢 Submit your research today!
010
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
With LMD: www.sciencedirect.com/journal/labm... 🔓 All articles are Open Access 💡 Authors publish with no APC fees (APC USD 2,300 covered by Ruijin Hospital) 🔬 Rigorous peer review by international experts 🌎 Global dissemination through an international publishing platform
000
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
🚀 Publish your research with LabMed Discovery! Looking for a global platform to share your breakthroughs in Laboratory Medicine?https://www.sciencedirect.com/journal/labmed-discovery/ 🧬 Laboratory Diagnostics 🧬 Precision Medicine 🧬 Biomarkers Discovery 🧬 AI-assisted Diagnosis
000
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
LabMed Discovery @LabMedDiscovery LabMed Discovery participated in organizing the “Health Science Communication Workshop” in Shanghai . Over 100 experts from journals, universities, hospitals, and communication platforms gathered in Shanghai
000
LabMed Discovery @labmed2025.bsky.social · 25/07/2026
Point-of-care biosensors for monkey pox detection @digital-science.com 🦋 app.dimensions.ai/details/publ...
app.dimensions.ai
000
LabMed Discovery @labmed2025.bsky.social · 18/07/2026
🦋The research addresses the adoption paradox of artificial intelligence in computational pathology, highlighting the gap between advanced AI models and their limited use in clinical practice. app.dimensions.ai/details/publ...
app.dimensions.ai
000
LabMed Discovery @labmed2025.bsky.social · 11/07/2026
💡 Could dietary intervention boost CAR-T cell therapy? New @LabMedDiscovery review explores the diet-ferroptosis-immunity axis. Lower PUFA/MUFA ratios promote membrane resistance to peroxidation, enhancing T cell persistence and anti-tumor activity. 🔗 doi.org/10.1016/j.lm...
010
LabMed Discovery @labmed2025.bsky.social · 11/07/2026
🎯 Tiny particles, big impact on heart health. Metal nanomaterials + LDI-MS = a powerful new approach to detecting cardiovascular biomarkers. 🔗 doi.org/10.1016/j.lm...
100